Aclaris Therapeutics (ACRS)
(Delayed Data from NSDQ)
$1.91 USD
-0.04 (-2.05%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.88 -0.03 (-1.57%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Aclaris Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ACRS 1.91 -0.04(-2.05%)
Will ACRS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ACRS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ACRS
Strength Seen in Xencor (XNCR): Can Its 7.3% Jump Turn into More Strength?
Aclaris Therapeutics (ACRS) Reports Q2 Loss, Beats Revenue Estimates
ACRS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Harrow (HROW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Aclaris Therapeutics (ACRS) Expected to Beat Earnings Estimates: Should You Buy?
Aclaris Therapeutics (ACRS) Reports Q1 Loss, Misses Revenue Estimates
Other News for ACRS
200 Day Moving Average Support appears for ACRS after 2.05% move
ACRS Crossed Above 20 Day Moving Average on September 19
New Downtrend appears for ACRS after 1.63% move
Doji - Bullish? appears for ACRS after 0.0% move
Fell Below 20 Day Moving Average appears for ACRS after 5.64% move